The impact of patient registration on utilisation and quality of care: a propensity score matching and staggered difference-in-differences analysis of a cohort of 16,775 people with type 2 diabetes.

ABSTRACT

BACKGROUND: In 2012, Luxembourg introduced a Referring Doctor (RD) policy, whereby patients voluntarily register with a primary care practitioner, who coordinates patients' health care and ensures optimal follow-up. We contribute to the limited evidence base on patient registration by evaluating the effects of the RD policy. METHODS: We used data on 16,775 people with type 2 diabetes on oral medication (PWT2D), enrolled with the Luxembourg National Fund from 2010 to 2018. We examined the utilisation of primary and specialist outpatient care, quality of care process indicators, and reimbursed prescribed medicines over the short- (until 2015) and medium-term (until 2018). We used propensity score matching to identify comparable groups of patients with and without an RD. We applied difference-in-differences methods that accounted for patients' registration with an RD in different years. RESULTS: There was low enrolment of PWT2D in the RD programme. The differences-in-differences parallel trends assumption was not met for general practitioner (GP) consultations, GP home visits (medium-term), HbA1c test (short-term), complete cholesterol test (short-term), kidney function (urine) test (short-term), and the number of repeat prescribed cardiovascular system medicines (short-term). There was a statistically significant increase in the number of HbA1c tests (medium-term 0.09 (95% CI 0.01 to 0.18)); kidney function (blood) tests in the short- (0.10 (95% CI 0.01 to 0.19)) and medium-term (0.11 (95% CI 0.03 to 0.20)); kidney function (urine) tests (medium-term 0.06 (95% CI 0.02 to 0.10)); repeat prescribed medicines in the short- (0.19 (95% CI 0.03 to 0.36)) and medium-term (0.18 (95% CI 0.02 to 0.34)); and repeat prescribed cardiovascular system medicines (medium-term 0.08 (95% CI 0.01 to 0.15)). Sensitivity analyses also revealed increases in kidney function (urine) tests (short-term 0.07 (95% CI 0.03 to 0.11)) and dental consultations (short-term 0.06, 95% CI 0.00 to 0.11), and decreases in specialist consultations (short-term -0.28, 95% CI -0.51 to -0.04; medium-term -0.26, 95% CI -0.49 to -0.03). CONCLUSIONS: The RD programme had a limited effect on care quality indicators and reimbursed prescribed medicines for PWT2D. Future research should extend the analysis beyond this cohort and explore data linkage to include clinical outcomes and socio-economic characteristics.